Arzoxifene: a promising new selective estrogen receptor modulator for clinical chemoprevention of breast cancer.
Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire 03755, USA. michael.sporn@dartmouth.edu
Michael B
MB
Sporn
D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D015394:Molecular Structure; D009367:Neoplasm Staging; D010880:Piperidines / Q000737:chemistry / Q000627:therapeutic use*; D020849:Raloxifene Hydrochloride / Q000737:chemistry / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D013876:Thiophenes / Q000737:chemistry / Q000627:therapeutic use*
D016588:Anticarcinogenic Agents; D010880:Piperidines; D020845:Selective Estrogen Receptor Modulators; D013876:Thiophenes; D020849:Raloxifene Hydrochloride; C115121:LY 353381